Dr. David Crawford Compares Degarelix and LHRH Agonists

onclivetv has 407 videos Subscribe Here

Description: E. David Crawford, MD, professor in Surgery and Radiation Oncology and the head of Urologic Oncology at the University of Colorado, Anschutz Medical Campus, discusses research that led to the 2008 approval of degarelix as a treatment for men with prostate cancer.

To view more prostate cancer resources, visit
Shared By : onclivetv
Posted on : 09/10/13
Added : 4 years ago
Category : Prostate Cancer

More From onclivetv

Nothing found.